Tokyo Tape
Sign in
← I'rom Group

Quarterly report · Q3

2372.TEDINET S100SRTF
Period2023-04-01 → 2023-12-31
Filed2024-02-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
MetricValuePeriodScopeSource row
Revenue¥12.9bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥18.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥13.9bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥810m2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥3.0bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥1.1bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥3.3bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.9bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥1.3bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥3.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥972m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.5bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥972m2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥2.2bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥36.5bnat 2023-12-31Cons.Assets
Total assets¥35.1bnat 2023-03-31Cons.Assets
Total assets¥32.2bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥24.2bnat 2023-12-31Cons.Liabilities
Total liabilities¥23.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥12.4bnat 2023-12-31Cons.Net assets
Net assets / equity¥12.2bnat 2023-03-31Cons.Net assets
Net assets / equity¥11.8bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥7.3bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥9.4bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥80.332023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-9.892023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥210.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥185.132022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.052022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥210.062022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥184.942022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio33.8%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio34.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio36.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 64
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-12-31¥265m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-12-31¥224m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-12-31¥41m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31−¥566m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥3.5bn
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-12-31¥0
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥3.5bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥1.4bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue2023-04-01 → 2023-12-31¥2.3bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.0bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentsegment profit2023-04-01 → 2023-12-31−¥130m
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue2023-04-01 → 2023-12-31¥5.4bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue external2023-04-01 → 2023-12-31¥4.4bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥938m
jpcrp040300-q3r_E05352-000CROreportable segmentsegment profit2023-04-01 → 2023-12-31¥51m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue2023-04-01 → 2023-12-31¥1.5bn
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue external2023-04-01 → 2023-12-31¥801m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥664m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentsegment profit2023-04-01 → 2023-12-31¥3m
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue2023-04-01 → 2023-12-31¥7.0bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue external2023-04-01 → 2023-12-31¥6.4bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥617m
jpcrp040300-q3r_E05352-000SMOreportable segmentsegment profit2023-04-01 → 2023-12-31¥2.8bn
—segment totalrevenue2023-04-01 → 2023-12-31¥16.1bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥12.6bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥3.4bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥2.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥16.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥12.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥3.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥101m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥55m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥46m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31−¥67m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥951m
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-12-31¥2m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥953m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.2bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue2022-04-01 → 2022-12-31¥1.0bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.0bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentsegment profit2022-04-01 → 2022-12-31−¥102m
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue2022-04-01 → 2022-12-31¥4.1bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue external2022-04-01 → 2022-12-31¥4.0bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥97m
jpcrp040300-q3r_E05352-000CROreportable segmentsegment profit2022-04-01 → 2022-12-31−¥70m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue external2022-04-01 → 2022-12-31¥818m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥691m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentsegment profit2022-04-01 → 2022-12-31¥72m
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue2022-04-01 → 2022-12-31¥8.1bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue external2022-04-01 → 2022-12-31¥8.0bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥115m
jpcrp040300-q3r_E05352-000SMOreportable segmentsegment profit2022-04-01 → 2022-12-31¥4.4bn
—segment totalrevenue2022-04-01 → 2022-12-31¥14.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥13.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥907m
—segment totalsegment profit2022-04-01 → 2022-12-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥14.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥13.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥953m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥4.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 410
ItemContextValueUnit
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member230800
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0187
Number of shares held in own name treasury shares etcCurrentQuarterInstant230800
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant230800
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0187
Cash and depositsPrior1YearInstant9386000000JPY
Cash and depositsCurrentQuarterInstant7250000000JPY
Accounts receivable tradePrior1YearInstant3389000000JPY
Accounts receivable tradeCurrentQuarterInstant3403000000JPY
Merchandise and finished goodsPrior1YearInstant80000000JPY
Merchandise and finished goodsCurrentQuarterInstant95000000JPY
Work in processPrior1YearInstant345000000JPY
Work in processCurrentQuarterInstant405000000JPY
Raw materials and suppliesPrior1YearInstant387000000JPY
Raw materials and suppliesCurrentQuarterInstant377000000JPY
Short term loans receivablePrior1YearInstant689000000JPY
Short term loans receivableCurrentQuarterInstant661000000JPY
Other caPrior1YearInstant1448000000JPY
Other caCurrentQuarterInstant2365000000JPY
Allowance for doubtful accounts caPrior1YearInstant-398000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-384000000JPY
Current assetsPrior1YearInstant15328000000JPY
Current assetsCurrentQuarterInstant14175000000JPY
Buildings and structures netPrior1YearInstant7191000000JPY
Buildings and structures netCurrentQuarterInstant7293000000JPY
Tools furniture and fixtures netPrior1YearInstant1274000000JPY
Tools furniture and fixtures netCurrentQuarterInstant1955000000JPY
Machinery equipment and vehicles netPrior1YearInstant1059000000JPY
Machinery equipment and vehicles netCurrentQuarterInstant948000000JPY
LandPrior1YearInstant1272000000JPY
LandCurrentQuarterInstant2491000000JPY
Construction in progressPrior1YearInstant2206000000JPY
Construction in progressCurrentQuarterInstant2531000000JPY
Property plant and equipmentPrior1YearInstant13003000000JPY
Property plant and equipmentCurrentQuarterInstant15221000000JPY
GoodwillPrior1YearInstant915000000JPY
GoodwillCurrentQuarterInstant863000000JPY
Other iaPrior1YearInstant44000000JPY
Other iaCurrentQuarterInstant47000000JPY
Intangible assetsPrior1YearInstant959000000JPY
Intangible assetsCurrentQuarterInstant911000000JPY
Investment securitiesPrior1YearInstant2959000000JPY
Investment securitiesCurrentQuarterInstant3477000000JPY
Long term loans receivablePrior1YearInstant542000000JPY
Long term loans receivableCurrentQuarterInstant234000000JPY
Guarantee deposits ioaPrior1YearInstant1426000000JPY
Guarantee deposits ioaCurrentQuarterInstant1345000000JPY
Deferred tax assetsPrior1YearInstant114000000JPY
Deferred tax assetsCurrentQuarterInstant83000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass